Αρχική World News Mom with Breast Cancer Who Had A Year to Live Goes Into...

Mom with Breast Cancer Who Had A Year to Live Goes Into Remission After Trying Chemo Alternative SEF

Heather Giao was a healthy and active young mother in the prime of her life when she received the devastating news that would change her life. Her breast cancer diagnosis came as the ultimate shock, not just because it was a serious disease, but also because it had already metastasized to other areas of her body and was considered incurable.“Here I was, completely healthy, working full-time, going to the gym, raising a toddler,” she said. “Somehow I managed to get stage four cancer.”Heather’s prognosis was poor. If she decided to undergo chemotherapy treatment, she’d likely have only about a year to live. If she forewent treatment to preserve her quality of life during her final months, that number would be cut in half.“When you’re told you don’t have long to live and you have a little child who depends on you, that’s when it gets quite difficult,” Heather said. “So, if I did only have one year to live, I wanted it to be a good one. I wanted there to be good memories.”Heather knew she didn’t want to do chemotherapy. She didn’t want to be laid up in the hospital or on the couch at home not feeling like herself and knowing she never would again. She didn’t want to lose her gorgeous long hair she’d been growing for years and stop looking like the wife her husband had fallen in love with and the mother her son had always known. She wanted to live what was left of her life as actively and happily as she could.
Photo: Facebook/Heather GiaoBut Heather also wondered if there wasn’t an alternative treatment out there. So while she’d rejected traditional chemotherapy treatment and didn’t qualify for any clinical trials, she spent hours combing the internet for a different solution, one that would allow her to keep her quality of life.“I couldn’t wait for the doctors to get me in, for insurances to do prior authorizations,” she said. “I had to be my own advocate. It really became a full-time job.”What she found, after a thorough search, was Dr. Kenneth Matsumura, a researcher who has spent 20 years developing a type of chemotherapy alternative that doesn’t come with the normal side effects. Not only is his treatment method, called “side-effect free chemotherapy” or “SEF,” supposed to be easier to handle physically and mentally, it is also meant to allow the body to participate in its own healing by boosting the immune system rather than suppressing it. Essentially, the patient is given a “chemo antidote” along with their chemotherapy treatment to help the immune system continue to work properly, thereby enabling it to help fight off the cancer.
Photo: Facebook/Heather Giao“The immune cells in the body actually can participate in the killing of cancer cells during chemotherapy,” Matsumura said. “We reach remission — long-term remission in stage four diseases, in cancers like lung cancer that are considered totally hopeless. Instead of a 20 percent, 30 percent, maybe even 40 percent response rate to chemo, we were seeing nearly 90 to 100 percent response rates.”At first, however, Dr. Matsumura was hesitant to take on Heather’s case. “Her case actually worried me quite a bit,” he said. “It wasn’t just the type of cancer she had that was known to be kind of hopeless, but the way it had spread really worried me.”But Dr. Matsumura promised Heather one thing that she hadn’t been able to find anywhere else, and that clinched the deal for her: “He said, ‘I can’t guarantee that I’ll cure your cancer, but what I can promise you is that I’ll preserve your quality of life while I try.’”
Photo: Facebook/Heather GiaoDespite the fact that Heather’s insurance wouldn’t cover the treatment and she’d have to fly from Boise, Idaho, to Berkeley, California, every other week, she knew she had to take the risk. She began having treatments right away and also had a tumor removed from her breast. She was back at work right away the next week.Heather reports having no adverse side effects whatsoever and says her cancer was 80 percent gone in just four treatments. At that point, the cancer could only be detected in one spot near her left lung and in one lymph node.“Looking at me, nobody would ever know I was fighting stage four cancer” she said. “I didn’t lose my hair. I still maintained my appetite, I still had my energy. I was still able to work, I participate on a bowling league.”And Heather’s family, who initially thought she was crazy to try this new treatment, are also incredibly thankful for the quality of life she’s been able to maintain during treatment.
Photo: Facebook/Heather Giao“It’s let her live a life,” said Heather’s husband, John. “She goes to work, we can eat dinner together, she can play with her son.”But the best was still to come. Heather underwent a total of 11 rounds of Dr. Matsumura’s brand of chemo, some of which were just to be sure the cancer was completely gone. At the end of the treatment, Heather was officially in remission.“Four months after receiving chemotherapy, I had a CT scan, and there was no sign of cancer. Whatsoever,” she said.Heather isn’t entirely out of the woods yet; she needs to be cancer-free for a few years before her chances of the cancer coming back become pretty minimal. She’s also going to spend a long time paying off her medical bills and credit card debt associated with her treatment and travels. However, she’s grateful for the extra time she’s been given and the moments of fun and normalcy she’s been able to enjoy along the way.
Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...

Καρκίνος: Ευεργετική για τους καρκινοπαθείς η άσκηση

Σημαντικά ωφέλη προσφέρει η άσκηση, ακόμη και σε ασθενείς με καρκίνο. Οι περισσότεροι ασθενείς αγνοούν τα οφέλη που μπορεί να έχει γι’ αυτούς η συχνή...

Prostate Cancer

The article is provided by Scientific Communications Officer of NIPD Genetics, Ms Marina Charitou (MSc) Prostate Cancer Awareness Prostate cancer is the second most common cancer...
- Advertisment -

Ροή Ειδήσεων

ESMO 2020: New Treatments for Advanced Kidney Cancer, Prostate Cancer, and Bladder Cancer

The 2020 European Society for Medical Oncology (ESMO) Virtual Congress was held online from September 19 to September 21. In this podcast, Neeraj Agarwal,...

The UK Government’s spending review: Time to invest in the future of cancer care

This autumn, the chancellor Rishi Sunak will go to Parliament and set out the UK Government’s spending priorities in the Comprehensive Spending Review...

FDA Extends Approval of Pembrolizumab for Classical Hodgkin Lymphoma

On 14 October 2020, the US Food and Drug Administration (FDA) extended the approval of pembrolizumab (KEYTRUDA®, Merck Sharp & Dohme Corp.) for the...

31-Year-Old Mother Dies of Cancer After Her Chemotherapy Was Paused During the Pandemic

The COVID-19 pandemic has been a scary and difficult thing for most of the world, and it’s important to keep safety protocols in place...

For Esophageal Cancer, Immunotherapy Likely to Play Larger Role

October 19, 2020, by NCI Staff An esophagram using barium contrast shows the esophagus. Credit: iStock Immunotherapy may become part of early treatment for some people with...

Targeted Therapy Based on Molecular Profiling of Malignant Mesothelioma Tumours Is Feasible

Targeted therapy recommendations can be made based on the molecular profiles of tumour samples from patients with metastatic malignant mesothelioma (MM) according to findings...